Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of CenterWatch:
Hypertension (High Blood Pressure)
If you have high blood pressure or take medication for high blood pressure, you may qualify for this study.
The research site is in Dallas,...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Americans' Health May Decline: Report
Americans' health improved by 18 percent between 1990 and 2000, but has leveled off over the past four years...
WEDNESDAY, Dec. 3 -- Two newer breast imaging techniques will help doctors diagnose and stage breast cancer, but neither technique will replace standard mammography for the detection of breast cancer.
Both tests -- breast-specific gamma imaging...
WEDNESDAY, Dec. 3 -- There may be a link between depression and abdominal obesity in older people, according to researchers in Holland who studied almost 2,100 adults in their seventies.
The participants were screened for depression at the start of...
WEDNESDAY, Dec. 3 -- Children born by Caesarean section are at increased risk of asthma, according to Swiss researchers, who conducted long-term monitoring of the respiratory health of nearly 3,000 infants.
By the time they were 8 years old, 362...
Pharma Industry News
Abbott, Medtronic and Stryker YouTube videos fail to include required product warning statements
BOSTON (December 3, 2008) – Pharmaceutical and medical device companies are illegally advertising their products on YouTube, the Prescription...
WILMINGTON, Del., December 03, 2008 /PRNewswire-FirstCall/ -- AstraZeneca today announced the appointment of Graham Baker as Vice President and Chief Financial Officer of AstraZeneca North America.
Graham will be responsible for all Finance and...
Analysis: What can we learn from drug marketing efficiency?
LONDON, Dec. 2, 2008-With new drugs being reviewed by regulatory agencies and then released onto the market faster than ever before, patients' safety is being compromised, warns a study...
SOUTH SAN FRANCISCO, Calif. & OSAKA, Japan--(BUSINESS WIRE)--Dec 3, 2008 - Cell Genesys, Inc. (Nasdaq:CEGE) and Takeda Pharmaceutical Company Limited (TSE:4502), together with its wholly owned subsidiary Millennium: The Takeda Oncology Company,...
Communication about an Ongoing Safety Review
Innohep (tinzaparin sodium injection)
This information reflects FDA’s current analysis of available data concerning these drugs. Posting this information does not mean that FDA has concluded there...
New Drug Approvals
MONTVALE, N.J., December 01, 2008 /PRNewswire-FirstCall/ -- Barr Pharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved its subsidiary Duramed Pharmaceuticals, Inc.'s New Drug Application (NDA) for...
NEW YORK--(BUSINESS WIRE)--Nov 25, 2008 - The U.S. Food and Drug Administration (FDA) has granted Selzentry (maraviroc) full (traditional) approval for use in treatment-experienced adults with CCR5-tropic HIV-1 in combination with other...
RARITAN, N.J., November 21, 2008 /PRNewswire/ -- Millions of Americans with moderate to severe acute pain and their health-care providers will soon have a new treatment option. Today, Johnson & Johnson Pharmaceutical Research & Development, L.L.C.,...
PHILADELPHIA, November 20, 2008 /PRNewswire-FirstCall/ --GlaxoSmithKline today announced that the United States Food and Drug Administration (FDA) granted accelerated approval for Promacta (eltrombopag) for the treatment of thrombocytopenia in...
LONDON, Nov. 19, 2008-On 18 November 2008, the US FDA responded to AstraZeneca's Citizen Petition surrounding the company's concern about the approval of any generic version of Pulmicort Respules (budesonide inhalation suspension). While the FDA...
New Drug Applications
LONDON, Nov. 28, 2008-AstraZeneca today announced that MedImmune, its wholly owned biologics business, has received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) asking for additional information on motavizumab....
RARITAN, N.J., November 26, 2008 /PRNewswire/ -- Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (J&JPRD), today announced that it received a Complete Response letter from the U.S. Food and Drug Administration (FDA) regarding its New...
DEERFIELD, Ill., and OSAKA, Japan, November 24, 2008 /PRNewswire/ -- Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Global Research & Development Center, Inc., U.S., announced today that the Arthritis Advisory...
SAN DIEGO--(BUSINESS WIRE)--Nov 24, 2008 - Somaxon Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the in-licensing and development of proprietary product candidates for the treatment of diseases and disorders in the fields of...
LAVAL, QC, November 24, 2008 /PRNewswire-FirstCall/ - Labopharm Inc. today announced that its New Drug Application (NDA) for the Company's novel once-daily formulation of trazodone (DDS-04A), a serotonin antagonist reuptake inhibitor (SARI), for the...
Clinical Trials
ALBUQUERQUE, N.M., December 03, 2008 /PRNewswire/ -- The nation's first scientific study on the relationship between smoking and respiratory disease among Hispanic versus non-Hispanic white (NHW) women revealed that NHW women smokers were at greater...
HASBROUCK HEIGHTS, N.J.,Dec. 3, 2008--Nymox Pharmaceutical Corporation (NASDAQ: NYMX) reported today positive new data from a recently completed clinical trial of NX-1207, the Company’s investigational drug for BPH. The trial data shows that...
DALLAS--(BUSINESS WIRE)--Dec 3, 2008 - Memgen today announced that two of its clinical trials were selected for poster presentations at the annual meeting of the American Society of Hematology (ASH) on December 6-9.
Both presentations highlight...
CARLSBAD, Calif., Dec. 3 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. announced today that OncoGenex Pharmaceuticals, Inc. provided positive survival results from a randomized Phase 2 clinical trial of OGX-011 in combination with docetaxel...
BETHESDA, Md., December 03, 2008 /PRNewswire-FirstCall/ -- Micromet, Inc. , a biopharmaceutical company developing novel, proprietary antibodies for the treatment of cancer, inflammation and autoimmune diseases, will host a webcast and conference...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
